Newsroom

Scientist working with an analytical instrument in the laboratory.

News

Antimicrobial resistance is one of the greatest challenges facing modern medicine. A new class of programmable antibiotics known as asobiotics can be used to treat bacterial infections when classical antibiotics fail. A team of researchers from TWINCORE, Centre for Experimental and Clinical Infection Research, the RESIST Cluster of Excellence and from the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg has now studied, how bacteria adapt to asobiotics. They recently published their finding in Nature Communications. TWINCORE and HIRI are sites of the Helmholtz Centre for Infection Research (HZI) in cooperation with Hannover Medical School and Julius-Maximilians-Universität Würzburg, respectively.

31.08.2026

TWINCORE

HIRI

Nine people at a topping-out ceremony on a construction site symbolically strike a wooden beam with hammers.

News

On 28 August 2026, the Helmholtz Institute for One Health (HIOH) celebrated the completion of the structural shell of its new research building at the Berthold-Beitz-Platz campus together with guests from science, politics – including Bettina Martin, Minister for Science of Mecklenburg-Western Pomerania – and partner institutions. The €38 million project is jointly funded by the state of Mecklenburg-Western Pomerania, which is contributing €26.5 million, and the federal government.

28.08.2026

HIOH

Group photo of 10 people in front of two HZI banners

News

Dennis Rohde, a member of the German Bundestag and Parliamentary State Secretary at the Federal Ministry of Finance (BMF), visited the Braunschweig campus of the Helmholtz Centre for Infection Research (HZI) today. He was accompanied by Braunschweig’s Mayor, Dr. Thorsten Kornblum. The visit focused on discussions with the HZI management and researchers as well as insights into key research and infrastructure areas at the HZI.

26.08.2026

HZI Campus

News

Ebola viruses are among the most dangerous known human pathogens. Three species of Ebola virus have repeatedly caused major outbreaks on the African continent. Most outbreaks have been caused by the Zaire Ebola virus. Medicines and vaccines are available for this virus species. However, there are as yet no treatments or vaccines against the Bundibugyo Ebola virus, which is causing the current outbreak in the Democratic Republic of the Congo. This makes it considerably more difficult to combat the outbreak, which is already the largest Bundibugyo Ebola virus outbreak ever documented. A team of researchers at the German Primate Centre – Leibniz Institute for Primate Research (DPZ), at TWINCORE Centre for Experimental and Clinical Infection Research in Hannover, as well as at the University Medical Centre Hamburg-Eppendorf and the Charité – University Medicine Berlin has now investigated how the Bundibugyo Ebola virus enters cells and whether there is cross-protection from an already approved Zaire Ebola virus vaccine. The study was published in the journal The Lancet Infectious Diseases.

25.08.2026

TWINCORE

A scientist operates a bioreactor in the lab

News

The DZIF flagship project PANTIPA has reached an important milestone. Following successful preclinical work at the University Hospital Cologne and the Helmholtz Centre for Infection Research (HZI), the project is now entering the next stage of development, including process development and GMP-compliant manufacturing of a monoclonal antibody targeting Pseudomonas aeruginosa. The Celonic Group has been selected as a partner for process development and production. The goal of PANTIPA is to advance an innovative antibody therapy to the clinical trial stage, thereby creating new treatment options for patients with severe infections.

25.08.2026

HZI Campus

Two people in the lab, smiling at the camera

News

The SARS-CoV-2 coronavirus is constantly mutating. As a result, vaccines become less effective and need to be regularly adapted. This was the case in 2025 with the JN.1 variant. An interdisciplinary team from Hannover and Göttingen has now investigated how the immune system responds to adapted vaccines. The findings were published in Nature Communications.

17.08.2026

TWINCORE

HZI in the media

... zunehmen. Mit der Gründung des HIOH im Jahr 2021 als Standort des Braunschweiger Helmholtz-Zentrums für ...

31.08.2026

Management & Krankenhaus

... des neuen Forschungsgebäudes des Helmholtz-Instituts für One Health (HIOH) in Greifswald (Landkreis Vorpommern-Greifswald) gelegt

. ...

28.08.2026

Tagesschau

How Bacteria Develop Resistance to Antisense Antibiotics—and How Future Therapies Can Be Made Less Susceptible to It

28.08.2026

Bionity.COM

Wie man sich mit Mpox anstecken kann und warum sich Personen mit häufig wechselnden Sexpartnern impfen lassen sollten.

28.08.2026

Apotheken Umschau

Infection Research; the RESIST Cluster of Excellence; and the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg has

27.08.2026

Phys.org

... Arbeiten am Universitätsklinikum Köln und am Helmholtz-Zentrum für Infektionsforschung startet nun die Entwicklung und GMP- ...

26.08.2026

healthcare-in-europe.com

Infos: Herpesviren – Eine große Familie Helmholtz Zentrum für Infektionsforschung www.helmholtz-hzi.de/wissen/wissensportal/ ...

25.08.2026

SWR4 Rheinland-Pfalz

An einer weiteren Station veranschaulicht das Helmholtz-Institut für Pharmazeutische Forschung, wie die Entwicklung neuer ...

25.08.2026

MSN Deutschland

Technologien“ im HUMAN-Projekt am Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig . Im Mittelpunkt ihrer Arbeit steht ...

23.08.2026

Regional Heute

... Medizinischen Hochschule Hannover (MHH) und des Helmholtz-Zentrums für Infektionsforschung (HZI). Dafür setzten die Forschenden sechs ...

19.08.2026

Pharmazeutische Zeitung

... Arbeiten am Universitätsklinikum Köln und am Helmholtz-Zentrum für Infektionsforschung startet nun die Entwicklung und GMP- ...

19.08.2026

DeutschesGesundheitsPortal

available genomic resources. HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University.

14.08.2026

News Medical

Register now for the HZI newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.